Cahaba Wealth Management Inc. lowered its stake in UnitedHealth Group Inc (NYSE:UNH) by 0.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,807 shares of the healthcare conglomerate’s stock after selling 43 shares during the quarter. UnitedHealth Group makes up approximately 0.9% of Cahaba Wealth Management Inc.’s investment portfolio, making the stock its 15th largest position. Cahaba Wealth Management Inc.’s holdings in UnitedHealth Group were worth $2,941,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of UNH. IMS Capital Management acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $85,000. Worth Venture Partners LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $104,000. FNY Investment Advisers LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $106,000. Fort L.P. acquired a new position in shares of UnitedHealth Group in the second quarter valued at approximately $119,000. Finally, Polaris Greystone Financial Group LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $120,000. 85.28% of the stock is owned by hedge funds and other institutional investors.

Several research analysts have recently issued reports on UNH shares. Argus upped their price objective on UnitedHealth Group to $285.00 and gave the company a “buy” rating in a research note on Thursday, October 18th. Jefferies Financial Group upped their price objective on UnitedHealth Group from $270.00 to $311.00 and gave the company a “buy” rating in a research note on Wednesday, October 3rd. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, October 2nd. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $299.00 price objective for the company in a research note on Tuesday, September 25th. Finally, Bank of America upped their price objective on UnitedHealth Group from $315.00 to $320.00 and gave the company a “buy” rating in a research note on Wednesday, October 17th. One investment analyst has rated the stock with a hold rating and twenty-three have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $293.86.

In other news, Director Richard T. Burke sold 6,090 shares of the firm’s stock in a transaction that occurred on Wednesday, November 28th. The shares were sold at an average price of $281.72, for a total transaction of $1,715,674.80. Following the completion of the sale, the director now owns 1,711,584 shares of the company’s stock, valued at approximately $482,187,444.48. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kenneth Irwin Shine sold 163 shares of the firm’s stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $274.83, for a total transaction of $44,797.29. The disclosure for this sale can be found here. Company insiders own 0.87% of the company’s stock.

NYSE:UNH traded up $2.13 on Monday, reaching $249.80. 2,497,347 shares of the stock traded hands, compared to its average volume of 4,061,377. The company has a market capitalization of $234.39 billion, a PE ratio of 24.81, a P/E/G ratio of 1.23 and a beta of 0.88. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.69 and a current ratio of 0.69. UnitedHealth Group Inc has a 1-year low of $208.48 and a 1-year high of $287.94.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, beating analysts’ consensus estimates of $3.30 by $0.11. The business had revenue of $56.56 billion during the quarter, compared to the consensus estimate of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The company’s revenue for the quarter was up 12.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.66 EPS. Research analysts predict that UnitedHealth Group Inc will post 12.81 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This article was originally published by Marea Informative and is the sole property of of Marea Informative. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.mareainformativa.com/news/2019/01/14/unitedhealth-group-inc-unh-position-trimmed-by-cahaba-wealth-management-inc.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Should You Consider an Index Fund?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.